Armata Pharmaceuticals (FRA:TG1N) Sale Of Property, Plant, Equipment : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Armata Pharmaceuticals Sale Of Property, Plant, Equipment?

Armata Pharmaceuticals's sale of property, plant, equipment for the three months ended in Dec. 2024 was €0.00 Mil. It means Armata Pharmaceuticals gained €0.00 Mil from selling property, plant, and equipment. Armata Pharmaceuticals's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Sep. 2024 ), Armata Pharmaceuticals gained the same money from selling property, plant, and equipment in Dec. 2024 (€0.00 Mil).

Armata Pharmaceuticals Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Armata Pharmaceuticals's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Armata Pharmaceuticals Sale Of Property, Plant, Equipment Chart

Armata Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Sale Of Property, Plant, Equipment

Get a 7-Day Free Trial

0.01

Armata Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Sale Of Property, Plant, Equipment	Get a 7-Day Free Trial															-	-	-	-	-

Armata Pharmaceuticals Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Armata Pharmaceuticals Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Armata Pharmaceuticals's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Armata Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Armata Pharmaceuticals Inc (FRA:TG1N) » Definitions » Sale Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

ARMP:USA TG1N:Germany

Address

5005 McConnell Avenue, Los Angeles, CA, USA, 90066

Website

https://www.armatapharma.com

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Armata Pharmaceuticals Headlines

No Headlines